These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22238577)

  • 1. The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.
    Liggins J; Pihl RO; Benkelfat C; Leyton M
    PLoS One; 2012; 7(1):e28370. PubMed ID: 22238577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.
    Leyton M; aan het Rot M; Booij L; Baker GB; Young SN; Benkelfat C
    J Psychiatry Neurosci; 2007 Mar; 32(2):129-36. PubMed ID: 17353942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.
    Grimm O; Nägele M; Küpper-Tetzel L; de Greck M; Plichta M; Reif A
    Psychopharmacology (Berl); 2021 May; 238(5):1333-1342. PubMed ID: 33140215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Enhancement of Dopamine Neurotransmission Does Not Affect Illusory Pattern Perception.
    Smith E; Michalski S; Knauth K; Tuzsus D; Theis H; van Eimeren T; Peters J
    eNeuro; 2024 Jul; 11(7):. PubMed ID: 38997143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia.
    Sellnow RC; Newman JH; Chambers N; West AR; Steece-Collier K; Sandoval IM; Benskey MJ; Bishop C; Manfredsson FP
    Acta Neuropathol Commun; 2019 Jan; 7(1):8. PubMed ID: 30646956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans.
    Kunkel A; Asan L; Krüger I; Erfurt C; Ruhnau L; Caliskan EB; Hackert J; Wiech K; Schmidt K; Bingel U
    PLoS Biol; 2024 Sep; 22(9):e3002772. PubMed ID: 39316644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA.
    Gantz SC; Levitt ES; Llamosas N; Neve KA; Williams JT
    Cell Rep; 2015 Aug; 12(6):944-54. PubMed ID: 26235617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPA inhibits excitatory synaptic transmission in the rat nucleus tractus solitarius through release of dopamine.
    Ohi Y; Kodama D; Haji A
    Neuroscience; 2017 Sep; 360():18-27. PubMed ID: 28757247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?
    Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Kodaka F; Okumura M; Otsuka T; Suhara T
    J Neurosci; 2009 Oct; 29(43):13730-4. PubMed ID: 19864585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine modulates the reward experiences elicited by music.
    Ferreri L; Mas-Herrero E; Zatorre RJ; Ripollés P; Gomez-Andres A; Alicart H; Olivé G; Marco-Pallarés J; Antonijoan RM; Valle M; Riba J; Rodriguez-Fornells A
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3793-3798. PubMed ID: 30670642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
    Lindner MD; Plone MA; Mullins TD; Winn SR; Chandonait SE; Stott JA; Blaney TJ; Sherman SS; Emerich DF
    Exp Neurol; 1997 May; 145(1):130-40. PubMed ID: 9184116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa impairs probabilistic reversal learning in healthy young adults.
    Vo A; Seergobin KN; Morrow SA; MacDonald PA
    Psychopharmacology (Berl); 2016 Jul; 233(14):2753-63. PubMed ID: 27241710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic dopamine function measured with [
    Petzold J; Lee Y; Pooseh S; Oehme L; Beuthien-Baumann B; London ED; Goschke T; Smolka MN
    Sci Rep; 2019 Nov; 9(1):17927. PubMed ID: 31784559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsically regulated learning is modulated by synaptic dopamine signaling.
    Ripollés P; Ferreri L; Mas-Herrero E; Alicart H; Gómez-Andrés A; Marco-Pallares J; Antonijoan RM; Noesselt T; Valle M; Riba J; Rodriguez-Fornells A
    Elife; 2018 Aug; 7():. PubMed ID: 30160651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-DOPA reduces model-free control of behavior by attenuating the transfer of value to action.
    Kroemer NB; Lee Y; Pooseh S; Eppinger B; Goschke T; Smolka MN
    Neuroimage; 2019 Feb; 186():113-125. PubMed ID: 30381245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline impulsivity may moderate L-DOPA effects on value-based decision-making.
    Petzold J; Kienast A; Lee Y; Pooseh S; London ED; Goschke T; Smolka MN
    Sci Rep; 2019 Apr; 9(1):5652. PubMed ID: 30948756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic intermittent L-DOPA treatment induces changes in dopamine release.
    Lundblad M; af Bjerkén S; Cenci MA; Pomerleau F; Gerhardt GA; Strömberg I
    J Neurochem; 2009 Feb; 108(4):998-1008. PubMed ID: 19196428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dopamine content in lymphocytes from high-dose L-Dopa-treated Parkinson's disease patients.
    Rajda C; Dibó G; Vécsei L; Bergquist J
    Neuroimmunomodulation; 2005; 12(2):81-4. PubMed ID: 15785109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
    Globus M; Melamed E
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):211-5. PubMed ID: 6310691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.